...
首页> 外文期刊>Molecular biotechnology >Developing an extended genomic engineering approach based on recombineering to knock-in heterologous genes to Escherichia coli genome
【24h】

Developing an extended genomic engineering approach based on recombineering to knock-in heterologous genes to Escherichia coli genome

机译:基于重组将异源基因敲入大肠杆菌基因组的基础上,开发扩展的基因组工程方法

获取原文
获取原文并翻译 | 示例
           

摘要

Most existing genomic engineering protocols for manipulation of Escherichia coli are primarily focused on chromosomal gene knockout. In this study, a simple but systematic chromosomal gene knock-in method was proposed based on a previously developed protocol using bacteriophage λ (λ Red) and flippase-flippase recognition targets (FLP-FRT) recombinations. For demonstration purposes, DNA operons containing heterologous genes (i.e., pac encoding E. coli penicillin acylase and palB2 encoding Pseudozyma antarctica lipase B mutant) engineered with regulatory elements, such as strong/inducible promoters (i.e., P _(trc) and P _(araB)), operators, and ribosomal binding sites, were integrated into the E. coli genome at designated locations (i.e., lacZYA, dbpA, and lacI-mhpR loci) either as a gene replacement or gene insertion using various antibiotic selection markers (i.e., kanamycin and chloramphenicol) under various genetic backgrounds (i.e., HB101 and DH5α). The expression of the inserted foreign genes was subjected to regulation using appropriate inducers [isopropyl β-D-1-thiogalactopyranoside (IPTG) and arabinose] at tunable concentrations. The developed approach not only enables more extensive genomic engineering of E. coli, but also paves an effective way to "tailor" plasmid-free E. coli strains with desired genotypes suitable for various biotechnological applications, such as biomanufacturing and metabolic engineering.
机译:大多数现有的用于操纵大肠杆菌的基因组工程方案主要集中在染色体基因敲除上。在这项研究中,基于先前开发的使用噬菌体λ(λRed)和flippase-flippase识别靶标(FLP-FRT)重组的方案,提出了一种简单但系统的染色体基因敲入方法。出于演示目的,将含有异源基因(即,编码大肠杆菌青霉素酰基转移酶的pac和编码南极假单胞菌脂肪酶B突变体的palB2的异源基因)的DNA操纵子改造成带有调控元件,例如强/诱导型启动子(即P_(trc)和P_ (araB)),操纵子和核糖体结合位点整合到大肠杆菌基因组中指定位置(即lacZYA,dbpA和lacI-mhpR基因座)的位置上,作为基因替换或使用各种抗生素选择标记插入基因(在不同的遗传背景下(例如HB101和DH5α),即卡那霉素和氯霉素。使用合适的诱导剂[异丙基β-D-1-硫代半乳糖吡喃糖苷(IPTG)和阿拉伯糖]以可调的浓度对插入的外源基因的表达进行调节。开发的方法不仅可以实现更广泛的大肠杆菌基因组工程,而且为“定制”具有适合各种生物技术应用(例如生物制造和代谢工程)所需基因型的无质粒大肠杆菌菌株铺平了一条有效途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号